Skip to main content
Premium Trial:

Request an Annual Quote

Devyser to Distribute Paragon Genomics NGS Target Enrichment Tech in Italy

NEW YORK — Paragon Genomics said on Wednesday that it has signed an agreement for the distribution of its CleanPlex target enrichment technology and products in Italy by Swedish genetic test developer Devyser.

Launched in 2017, CleanPlex is based on a proprietary amplicon-based technology that biochemically removes nonspecific PCR products generated during highly multiplexed PCR reactions. The technology, which is used with next-generation sequencing assays, is available in ready-to-use or customized panels.

Under the terms of the deal, Devyser will distribute CleanPlex products and technology in Italy, with the potential to expand into additional markets. Financial and other terms were not disclosed.

In November, Fremont, California-based Paragon inked a deal to help Singular Genomics Systems validate its library preparation assays for use with its G4 sequencer.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.